Sign in to view content

Analysis of Antivascular Endothelial Growth Factor Utilization Trends and Prescriber Characteristics Based on Medicare Part B Claims Data: 2017-2022

Stephanie B Engelhard, MD

Video
Published 2025

Related

Retinal Vascular Disease Symposium
Annual Meeting Talks
2020
Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2021
Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab (PDS)
Jordan M. Graff, MD, FACS
Annual Meeting Talks
2021

Category: Socioeconomics

See more